BD biosciences - clontech:1109645 [16-025869]

Ended Awarded Last action

Contract number
HHSN26100031
Awardee
Awarding agency
Obligated
$33,759

Award facts

Opportunity
Contract value 100% obligated
$33,758.90 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
PSC
6810 Chemicals
Set-aside
No set-aside
Competition
Not Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$255
Original award $34,014

About this award

The National Cancer Institute issued a delivery order to Roche Diagnostics Corporation on February 26, 2016, with a ceiling value of $33,758.90 for in vitro diagnostic products and services.

Place of performance is Bethesda, MD. The order was priced firm fixed price with an ultimate completion date of December 9, 2019. No set-aside was used.

Quick answers

Who was awarded contract HHSN26100031?

HHSN26100031 was awarded to Roche Diagnostics Corporation by National Cancer Institute (National Institutes of Health) on February 26, 2016.

How much is contract HHSN26100031 worth?

The government has obligated $33,759 on HHSN26100031.

Is contract HHSN26100031 an order under another contract?

Yes. HHSN26100031 is a delivery order under HHSN261201500001I, an indefinite delivery contract.

Was contract HHSN26100031 competed?

The extent of competition for HHSN26100031 was not competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award